Protagenic Therapeutics, Inc.\new Proceeds from Issuance of Secured Debt
Protagenic Therapeutics, Inc.\new (PTIX) reported Proceeds from Issuance of Secured Debt of $150.00 thousand for the 6-month period ending 2015-12-31, per its 10-Q filed 2016-03-11.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSecuredDebt · last filed 2016-03-11
- Protagenic Therapeutics, Inc.\new proceeds from issuance of secured debt for the quarter ending 2015-12-31 was $100.00K, a 58.32% decline year-over-year.
- Protagenic Therapeutics, Inc.\new proceeds from issuance of secured debt for the quarter ending 2015-09-30 was $50.00K, a 55455.56% increase year-over-year.
- Protagenic Therapeutics, Inc.\new proceeds from issuance of secured debt for the quarter ending 2015-06-30 was $100.00K.
- Protagenic Therapeutics, Inc.\new proceeds from issuance of secured debt for the quarter ending 2015-03-31 was $0.00.
- Protagenic Therapeutics, Inc.\new proceeds from issuance of secured debt for fiscal 2015 was $340.00K.
| Period end | Proceeds from Issuance of Secured Debt 3 month | Proceeds from Issuance of Secured Debt 6 month | Proceeds from Issuance of Secured Debt 9 month | Proceeds from Issuance of Secured Debt 12 month |
|---|---|---|---|---|
| 2015-12-31 | $100.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-03-11 | $150.00K 10-Q · filed 2016-03-11 | $250.00K derived: sum of 3 quarters · filed 2016-03-11 | $250.00K derived: sum of 4 quarters · filed 2016-03-11 |
| 2015-09-30 | $50.00K 10-Q · filed 2015-11-13 | $150.00K derived: sum of 2 quarters · filed 2015-11-13 | $150.00K derived: sum of 3 quarters · filed 2015-11-13 | $389.91K derived: sum of 4 quarters · filed 2015-11-13 |
| 2015-06-30 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-25 | $100.00K derived: sum of 2 quarters · filed 2015-09-25 | $339.91K derived: sum of 3 quarters · filed 2015-09-25 | $340.00K 10-K · filed 2015-09-25 |
| 2015-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-11 | $239.91K derived: sum of 2 quarters · filed 2015-05-11 | $240.00K 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $239.91K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-06 | $240.00K 10-Q · filed 2015-02-06 | ||
| 2014-09-30 | $90.00 10-Q · filed 2014-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |